Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Baricitinib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Baricitinib 4mg tablets
1001030ACAAAAAA
|
Baricitinib | Baricitinib | Musculoskeletal and Joint Diseases | 29 |
|
Baricitinib 2mg tablets
1001030ACAAABAB
|
Baricitinib | Baricitinib | Musculoskeletal and Joint Diseases | 2 |
|
Olumiant 4mg tablets
1001030ACBBAAAA
|
Olumiant | Baricitinib | Musculoskeletal and Joint Diseases | 2 |
|
Olumiant 2mg tablets
1001030ACBBABAB
|
Olumiant | Baricitinib | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.